국가: 미국
언어: 영어
출처: NLM (National Library of Medicine)
CALCIUM ACETATE (UNII: Y882YXF34X) (CALCIUM CATION - UNII:2M83C4R6ZB)
Pharmin USA, LLC
CALCIUM ACETATE
CALCIUM ACETATE 667 mg
ORAL
Calcium Acetate Tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).
Dietary Supplement
CALCIUM ACETATE 667 MG- CALCIUM ACETATE TABLET, COATED PHARMIN USA, LLC ---------- CALCIUM ACETATE TABLETS 667 MG HIGHLIGHTS OF PRESCRIBING INFORMATION DISPENSED UNDER CLINICAL SUPERVISION* * CALCIUM ACETATE 667MG TABLETS ARE CATEGORIZED AS A HUMAN PRESCRIPTION DRUG OR SUPPLEMENT IN THE USA. THIS PRODUCT SHOULD BE DISPENSED UNDER CLINICAL SUPERVISION IN COMPLIANCE WITH ALL REGULATIONS AS SET FORTH BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION. 1 INDICATIONS AND USAGE Calcium Acetate Tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). 2 DOSAGE AND ADMINISTRATION The recommended initial dose of Calcium Acetate Tablets for the adult dialysis patient is 2 capsules with each meal. Increase the dose gradually to lower serum phosphorus levels to the target range, as long as hypercalcemia does not develop. Most patients require 3-4 capsules with each meal. 3 DOSAGE FORMS AND STRENGTHS Tablet: 667 mg calcium acetate per tablet. 4 CONTRAINDICATIONS Patients with hypercalcemia. 5 WARNINGS AND PRECAUTIONS _5.1 HYPERCALCEMIA_ Patients with end stage renal disease may develop hypercalcemia when treated with calcium, including calcium acetate. Avoid the use of calcium supplements, including calcium-based nonprescription antacids, concurrently with calcium acetate. An overdose of calcium acetate may lead to progressive hypercalcemia, which may require emergency measures. Therefore, early in the treatment phase during the dosage adjustment period, monitor serum calcium levels twice weekly. Should hypercalcemia develop, reduce the calcium acetate dosage or discontinue the treatment, depending on the severity of hypercalcemia. More severe hypercalcemia (Ca>12 mg/dL) is associated with confusion, delirium, stupor and coma. Severe hypercalcemia can be treated by acute hemodialysis and discontinuing calcium acetate therapy.Mild hypercalcemia (10.5 to 11.9 mg/dL) may be asymptomatic or manifest as constipation, anorexia, nausea, and vomiting. Mild hypercalcemia is usual 전체 문서 읽기